• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

越南儿童朗格汉斯细胞组织细胞增多症的病理特征及BRAF V600E状态研究

A study of pathological characteristics and BRAF V600E status in Langerhans cell histiocytosis of Vietnamese children.

作者信息

Phan Thu Dang Anh, Phung Bao Gia, Duong Tu Thanh, Hoang Vu Anh, Ngo Dat Quoc, Trinh Nguyen Dinh The, Tran Tung Thanh

机构信息

Department of Pathology, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.

Department of Pathology, City Children Hospital, Ho Chi Minh City, Vietnam.

出版信息

J Pathol Transl Med. 2021 Mar;55(2):112-117. doi: 10.4132/jptm.2020.11.30. Epub 2021 Jan 27.

DOI:10.4132/jptm.2020.11.30
PMID:33494131
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7987525/
Abstract

BACKGROUND

Langerhans cell histiocytosis (LCH) is more common in children than adults and involves many organs. In children, the BRAF V600E mutation is associated with recurrent and high-risk LCH.

METHODS

We collected paraffin blocks of 94 pediatric LCH patients to detect BRAF V600E mutation by sequencing. The relationship between BRAF V600E status and clinicopathological parameters were also critically analyzed.

RESULTS

BRAF V600E mutation exon 15 was detected in 45 cases (47.9%). Multiple systems LCH showed a significantly higher BRAF V600E mutation rate than a single system (p=.001). No statistical significance was evident for other clinical characteristics such as age, sex, location, risk organs involvement, and CD1a expression.

CONCLUSIONS

In Vietnamese LCH children, the proportion of BRAF V600E mutational status was relatively high and related to multiple systems.

摘要

背景

朗格汉斯细胞组织细胞增多症(LCH)在儿童中比成人更常见,且累及多个器官。在儿童中,BRAF V600E突变与复发性和高危LCH相关。

方法

我们收集了94例儿童LCH患者的石蜡块,通过测序检测BRAF V600E突变。还对BRAF V600E状态与临床病理参数之间的关系进行了严格分析。

结果

45例(47.9%)检测到BRAF V600E突变外显子15。多系统LCH的BRAF V600E突变率显著高于单系统(p = 0.001)。年龄、性别、部位、累及风险器官和CD1a表达等其他临床特征无明显统计学意义。

结论

在越南LCH儿童中,BRAF V600E突变状态的比例相对较高,且与多系统有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bbc/7987525/e57180de84b9/jptm-2020-11-30f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bbc/7987525/1fe16c0f6a54/jptm-2020-11-30f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bbc/7987525/e57180de84b9/jptm-2020-11-30f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bbc/7987525/1fe16c0f6a54/jptm-2020-11-30f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bbc/7987525/e57180de84b9/jptm-2020-11-30f2.jpg

相似文献

1
A study of pathological characteristics and BRAF V600E status in Langerhans cell histiocytosis of Vietnamese children.越南儿童朗格汉斯细胞组织细胞增多症的病理特征及BRAF V600E状态研究
J Pathol Transl Med. 2021 Mar;55(2):112-117. doi: 10.4132/jptm.2020.11.30. Epub 2021 Jan 27.
2
The Value of BRAF VE1 Immunoexpression in Pediatric Langerhans Cell Histiocytosis.BRAF VE1免疫表达在儿童朗格汉斯细胞组织细胞增多症中的价值
Fetal Pediatr Pathol. 2022 Aug;41(4):558-567. doi: 10.1080/15513815.2020.1857483. Epub 2020 Dec 9.
3
Frequent mutation has no effect on tumor invasiveness in patients with Langerhans cell histiocytosis.在朗格汉斯细胞组织细胞增多症患者中,频繁突变对肿瘤侵袭性无影响。
Biomed Rep. 2013 May;1(3):365-368. doi: 10.3892/br.2013.62. Epub 2013 Jan 25.
4
[BRAF-V600E mutation and its clinical significance in children with Langerhans cell histiocytosis].[BRAF-V600E突变及其在朗格汉斯细胞组织细胞增多症患儿中的临床意义]
Zhongguo Dang Dai Er Ke Za Zhi. 2018 Apr;20(4):290-294. doi: 10.7499/j.issn.1008-8830.2018.04.007.
5
Association between clinicopathologic characteristics and BRAF expression in Chinese patients with Langerhans cell histiocytosis.中国朗格汉斯细胞组织细胞增生症患者临床病理特征与 BRAF 表达的相关性。
Thorac Cancer. 2019 Oct;10(10):1984-1992. doi: 10.1111/1759-7714.13179. Epub 2019 Aug 23.
6
V600E Mutation: A Significant Biomarker for Prediction of Disease Relapse in Pediatric Langerhans Cell Histiocytosis.V600E突变:小儿朗格汉斯细胞组织细胞增多症疾病复发预测的重要生物标志物。
Pediatr Dev Pathol. 2019 Oct;22(5):449-455. doi: 10.1177/1093526619847859. Epub 2019 May 9.
7
Frequency detection of BRAF V600E mutation in a cohort of pediatric langerhans cell histiocytosis patients by next-generation sequencing.采用下一代测序技术检测儿科朗格汉斯细胞组织细胞增生症患者中 BRAF V600E 突变的频率。
Orphanet J Rare Dis. 2021 Jun 11;16(1):272. doi: 10.1186/s13023-021-01912-3.
8
[BRAF V600E Mutation in Chinese Patients with Langerhans Cell Histiocytosis and Its Clinical Significance].[中国朗格汉斯细胞组织细胞增多症患者的BRAF V600E突变及其临床意义]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015 Apr;23(2):526-32. doi: 10.7534/j.issn.1009-2137.2015.02.045.
9
BRAF-V600E mutations in plasma and peripheral blood mononuclear cells correlate with prognosis of pediatric Langerhans cell histiocytosis treated with first-line therapy.BRAF-V600E 突变在血浆和外周血单个核细胞中与一线治疗后儿童朗格汉斯细胞组织细胞增生症的预后相关。
Pediatr Blood Cancer. 2024 Sep;71(9):e31099. doi: 10.1002/pbc.31099. Epub 2024 Jun 6.
10
BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy.BRAF突变与高危朗格汉斯细胞组织细胞增多症相关,并与一线治疗耐药性增加有关。
J Clin Oncol. 2016 Sep 1;34(25):3023-30. doi: 10.1200/JCO.2015.65.9508. Epub 2016 Jul 5.

引用本文的文献

1
Pathologic characteristics of histiocytic and dendritic cell neoplasms.组织细胞和树突状细胞肿瘤的病理特征。
Blood Res. 2024 May 7;59(1):18. doi: 10.1007/s44313-024-00015-9.

本文引用的文献

1
High Prevalence of Mutations in Langerhans Cell Histiocytosis of Head and Neck in Chinese Patients.中国患者头颈部朗格汉斯细胞组织细胞增多症中突变的高发生率
Int J Surg Pathol. 2019 Dec;27(8):836-843. doi: 10.1177/1066896919855774. Epub 2019 Jun 17.
2
V600E Mutation: A Significant Biomarker for Prediction of Disease Relapse in Pediatric Langerhans Cell Histiocytosis.V600E突变:小儿朗格汉斯细胞组织细胞增多症疾病复发预测的重要生物标志物。
Pediatr Dev Pathol. 2019 Oct;22(5):449-455. doi: 10.1177/1093526619847859. Epub 2019 May 9.
3
The use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosis.
BRAF V600E突变特异性免疫组织化学在儿童朗格汉斯细胞组织细胞增多症中的应用
Hematol Oncol. 2018 Feb;36(1):307-315. doi: 10.1002/hon.2388. Epub 2017 Feb 20.
4
BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy.BRAF突变与高危朗格汉斯细胞组织细胞增多症相关,并与一线治疗耐药性增加有关。
J Clin Oncol. 2016 Sep 1;34(25):3023-30. doi: 10.1200/JCO.2015.65.9508. Epub 2016 Jul 5.
5
Analysis of the BRAFV600E mutation in 19 cases of Langerhans cell histiocytosis in Japan.日本19例朗格汉斯细胞组织细胞增多症中BRAFV600E突变的分析。
Hematol Oncol. 2017 Sep;35(3):329-334. doi: 10.1002/hon.2293. Epub 2016 Apr 4.
6
BRAF and MAP2K1 mutations in Langerhans cell histiocytosis: a study of 50 cases.朗格汉斯细胞组织细胞增多症中BRAF和MAP2K1突变:50例病例研究
Hum Pathol. 2016 Jun;52:61-7. doi: 10.1016/j.humpath.2015.12.029. Epub 2016 Feb 1.
7
B-Raf Inhibition in the Clinic: Present and Future.B-Raf 抑制在临床上的应用:现状与未来。
Annu Rev Med. 2016;67:29-43. doi: 10.1146/annurev-med-090514-030732.
8
Treatment of Langerhans cell histiocytosis: role of BRAF/MAPK inhibition.朗格汉斯细胞组织细胞增多症的治疗:BRAF/丝裂原活化蛋白激酶抑制的作用
Hematology Am Soc Hematol Educ Program. 2015;2015:565-70. doi: 10.1182/asheducation-2015.1.565.
9
BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.前体细胞与分化树突状细胞中BRAF-V600E的表达定义了临床上不同的朗格汉斯细胞组织细胞增多症风险组。
J Exp Med. 2015 Feb 9;212(2):281. doi: 10.1084/jem.2013097701202015c. Epub 2015 Feb 2.
10
Activating BRAF V600E mutation in aggressive pediatric Langerhans cell histiocytosis: demonstration by allele-specific PCR/direct sequencing and immunohistochemistry.侵袭性儿童朗格汉斯细胞组织细胞增多症中 BRAF V600E 激活突变:通过等位基因特异性 PCR/直接测序和免疫组织化学证实
Am J Surg Pathol. 2014 Dec;38(12):1644-8. doi: 10.1097/PAS.0000000000000304.